Evidence map›Paper›PMID 34535170›Full record

Trial reportImplementation science : IS2021

Organizational contextual factors that predict success of a quality improvement collaborative approach to enhance integrated HIV-tuberculosis services: a sub-study of the Scaling up TB/HIV Integration trial.

Santhanalakshmi Gengiah, Catherine Connolly, Nonhlanhla Yende-Zuma, Pierre M Barker, Andrew J Nunn, Nesri Padayatchi, Myra Taylor, Marian Loveday, Kogieleum Naidoo

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Implementation science : IS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02654613 (Addressing Challenges in Scaling up TB and HIV Treatment Integration in Public Health Settings in South Africa), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02654613 nacompletednot on this map

Addressing Challenges in Scaling up TB and HIV Treatment Integration in Public Health Settings in South Africa

TypeinterventionalSponsorCentre for the AIDS Programme of Research in South AfricaRan2015 to 2020Enrolled8,000ConditionsHIV, TuberculosisArmsQuality Improvement Model of Care
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Santhanalakshmi GengiahCentre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private Bag X7 Congella, Durban, 4013, South Africa. Santhana.Gengiah@caprisa.org.ORCID 0000-0003-2890-7248
Catherine ConnollySchool of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Nonhlanhla Yende-ZumaCentre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private Bag X7 Congella, Durban, 4013, South Africa.
Pierre M BarkerInstitute for Healthcare Improvement, Cambridge, MA, USA.
Andrew J NunnMedical Research Council, Clinical Trials Unit at University College London (UCL), London, UK.
Nesri PadayatchiCentre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private Bag X7 Congella, Durban, 4013, South Africa.
Myra TaylorSchool of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Marian Loveday *CAPRISA-MRC TB-HIV Pathogenesis and Treatment Research Unit, Durban, South Africa.
Kogieleum Naidoo *Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private Bag X7 Congella, Durban, 4013, South Africa.
South African Medical Research Council · ZAUniversity of KwaZulu-Natal · ZACentre for the AIDS Programme of Research in South Africa · ZAMRC Clinical Trials Unit at UCL · GBUniversity of North Carolina at Chapel Hill · US

Funding

Developing Research Innovation, Localization and Leadership in South Africa (DRILL)D43TW010131 · FIC · UNIVERSITY OF KWAZULU-NATAL · PI BRYSIEWICZ, PETRA, MOSHABELA, MOSA · 2015 to 2019
$3.2M
FIC NIH HHS D43 TW010131Medical Research Council MC_PC_16022
6 · The paper itself

Abstract

backgroundA quality improvement (QI) collaborative approach to enhancing integrated HIV-Tuberculosis (TB) services may be effective in scaling up and improving the quality of service delivery. Little is known of the role of organizational contextual factors (OCFs) in influencing the success of QI collaboratives. This study aims to determine which OCFs were associated with improvement in a QI collaborative intervention to enhance integrated HIV-TB services delivery.

methodsThis is a nested sub-study embedded in a cluster-randomized controlled trial. Sixteen nurse supervisors (clusters) overseeing 40 clinics were randomized (1:1) to receive QI training and mentorship, or standard of care support (SOC). In the QI arm, eight nurse supervisors and 20 clinics formed a "collaborative" which aimed to improve HIV-TB process indicators, namely HIV testing, TB screening, isoniazid preventive therapy (IPT) initiations, viral load testing, and antiretroviral therapy for TB patients. OCFs measured at baseline were physical infrastructure, key staff, flexibility of clinic hours, monitoring data for improvement (MDI), and leadership support. Surveys were administered to clinic staff at baseline and month 12 to assess perceptions of supportiveness of contexts for change, and clinic organization for delivering integrated HIV-TB services. Linear mixed modelling was used to test for associations between OCFs and HIV-TB process indicators.

resultsA total of 209 clinic staff participated in the study; 97 (46.4%) and 112 (53.6%) from QI and SOC arms, respectively. There were no differences between the QI and SOC arms scores achieved for physical infrastructure (78.9% vs 64.7%; p = 0.058), key staff (95.8 vs 92; p = 0.270), clinic hours (66.9 vs 65.5; p = 0.900), MDI (63.3 vs 65; p = 0.875, leadership support (46.0 vs 57.4; p = 0.265), and perceptions of supportiveness of contexts for change (76.2 vs 79.7; p = 0.128 and clinic organization for delivering integrated HIV-TB services (74.1 vs 80.1; p = 0.916). IPT initiation was the only indicator that was significantly improved in the parent study. MDI was a significantly associated with increasing IPT initiation rates [beta coefficient (β) = 0.004; p = 0.004]. DISCUSSION: MDI is a practice that should be fostered in public health facilities to increase the likelihood of success of future QI collaboratives to improve HIV-TB service delivery.

trial registrationClinicaltrials.gov , NCT02654613 . Registered 01 June 2015.

Indexed as

HIV InfectionsTuberculosisHumansIsoniazidQuality ImprovementResearch DesignSouth AfricaIsoniazidCluster-randomized trialHIV-TB integrationOrganizational contextual factorsQuality improvement collaborativesSouth Africa

Identifiers

PMID34535170
PMCPMC8447673
OpenAlexW3199028206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.